Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-01 Metzger Michael A President and COO Option exercise · Stock Options (Right to buy) −15,000 0
2021-01-31 Morrison Briggs Chief Executive Officer Other acquisition +1,771 $12.00 $21K 48,336
2021-01-31 Meyers Michael L. SVP, Chief Medical Officer Other acquisition +1,771 $12.00 $21K 15,166
2020-12-01 Metzger Michael A President and COO Option exercise +15,000 $7.20 $108K 32,659
2020-12-01 Metzger Michael A President and COO Sale −15,000 $22.97 $345K 17,659
2020-12-01 Metzger Michael A President and COO Option exercise · Employee Stock Option (right to buy) −15,000 0
2020-11-23 Ordentlich Peter Chief Scientific Officer Option exercise +24,288 $3.08 $75K 24,288
2020-11-23 Ordentlich Peter Chief Scientific Officer Option exercise +5,684 $3.08 $18K 29,972
2020-11-23 Ordentlich Peter Chief Scientific Officer Sale −5,684 $23.33 $133K 24,288
2020-11-23 Ordentlich Peter Chief Scientific Officer Sale −7,954 $23.58 $188K 16,334
2020-11-23 Ordentlich Peter Chief Scientific Officer Sale −16,334 $22.89 $374K 0
2020-11-23 Ordentlich Peter Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −24,288 0
2020-11-23 Ordentlich Peter Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −5,684 0
2020-11-10 Morrison Briggs Chief Executive Officer Option exercise +17,466 $7.20 $126K 64,031
2020-11-10 Morrison Briggs Chief Executive Officer Sale −17,466 $20.06 $350K 46,565
2020-11-10 Morrison Briggs Chief Executive Officer Option exercise · Stock Options (Right to buy) −17,466 0
2020-11-09 Morrison Briggs Chief Executive Officer Option exercise +62,938 $7.20 $453K 109,503
2020-11-09 Morrison Briggs Chief Executive Officer Sale −62,938 $20.04 $1.3M 46,565
2020-11-09 Morrison Briggs Chief Executive Officer Option exercise · Stock Options (Right to buy) −62,938 0
2020-11-04 Metzger Michael A President and COO Option exercise +100,000 $7.20 $720K 117,659

Page 21 of 25 · 500 trades